JNJ NYSE
Johnson & Johnson
1W: +0.4%
1M: +2.5%
3M: -3.9%
YTD: +12.4%
1Y: +54.2%
3Y: +58.2%
5Y: +56.0%
$234.34
+2.61 (+1.13%)
Weekly Expected Move ±2.9%
$214
$220
$227
$233
$240
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
3 bullish
0 neutral
0 bearish
Articles (24h)
3
Hourly Sentiment (24h)
0.76
Bullish
18 bullish
1 neutral
1 bearish
Articles (7d)
20
Daily Sentiment (7 Days)
Articles (100)
Healthcare Stocks Are on Fire -- Don't Miss These Opportunities
Catalyst Watch: Fedspeak ramps up post-Powell, core PCE, and box office blitz
J&J & Pfizer Face Patent Risks: Which Stock Looks Better Positioned?
Johnson & Johnson (JNJ) Outperforms Broader Market: What You Need to Know
BAYRY's Kerendia Label Expansion Application Gets Priority Review
The Zacks Analyst Blog Highlights Johnson & Johnson, Oracle, Netflix and Espey
Top Stock Reports for Johnson & Johnson, Oracle & Netflix
Pfizer Builds Oncology Growth Around Padcev and Pipeline Expansion
These 3 Dividend Stocks Are as Close to a Sure Thing as Investing Gets
ImmunityBio Says ANKTIVA Combo Outperformed Rival Bladder Cancer Therapies
3 Dividend Kings to Buy and Hold for 20 Years
J&J's Pipeline Progress & New Drugs Promise Stronger Long-Term Growth
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Meet the Dividend King With a Higher Credit Rating Than the U.S. Government
Supreme Court Hands Major Blow To Big Pharma's Fight Against Biden-Era Medicare Drug Pricing Law
Here's How Neuroscience Drugs Boost AbbVie's Q1 Sales Growth
Cancer Stocks That Are Advancing the Future of Oncology Care
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
3 Dividend Stocks Warren Buffett Would Buy in a Market Crash
Notable analyst calls this week: Dell, J&J and AMD stocks among top picks
How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?
Why Is Johnson & Johnson (JNJ) Down 3.5% Since Last Earnings Report?
Trump 'Most Favored Nation' drug policy risks China R&D takeover
CNS Drug Delivery Technologies Are Reshaping Alzheimer's and Biodefense Research
Tremfya, Icotyde Lead J&J's Post-Stelara Immunology Strategy
Halozyme's Q1 Earnings & Revenues Beat Estimates, Stock Up
Bayer Q1 Earnings Beat Estimates, Crop Science Unit Boosts Sales
Is Bristol Myers Squibb Stock Overvalued at Nearly $60? A Reality Check for Value Investors.
Income or Growth: Which Healthcare Stock Fits Your Portfolio Right Now?
Merck Stock Down 7% in a Month: Should Investors Hold or Exit?
2 Dividend Stocks That Are No-Brainer Buys in May
Trump says unaware of a plan to fire FDA commissioner
These Market Signals Alarm Me, but I Still See Profit Potential in These 3 Consumer Stocks
Trump to fire FDA commissioner Marty Makary: WSJ
3 Unstoppable Dividend King Stocks to Buy Right Now for Less Than $550
Darzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1
Wall Street lawyers charged in decade-long insider trading ring - reports
Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing Sites
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?
Is Johnson & Johnson Still the Ultimate Safe Dividend Stock to Buy?
CVS Health's Lower Medical Cost Ratio Lift Profit, Outlook
Trump's Drug Pricing Deals Could Lead To $529 Billion Savings For The Economy Over The Decade: Report
Male Labor Force Participation Slumps As US Job Growth Tilts Toward Healthcare
Robert F. Kennedy Jr. Wants To Take 'Clear And Decisive Action' On Psychiatric Drugs Amid 'Deprescribing' Push: Big Pharma Should Pay Attention
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
J&J boasts of Caplyta data as add-on therapy for depression
ABBV Stock Up 5% on Robust Q1 Performance: Time to Buy, Sell or Hold?
Most and least shorted mid-to mega-cap healthcare stocks in May
The Best Dividend Stocks to Buy and Hold Forever
Johnson & Johnson $JNJ Stock Holdings Lifted by Keybank National Association OH - MarketBeat
Got $1,000? Which of These Beaten-Down Healthcare Stocks Is Worth Buying?
S&P 500's Best‑Kept Secret: Why Healthcare Could Be 2026's Breakout Winner
Option Care Health downgraded at BofA on guidance cut
Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio
J&J ends development for several CAR-T large B-cell lymphoma programs
Bulldozer Maker Caterpillar Delivers Twice Nvidia's Returns — What's Behind The Move?
Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering
ABBV Beats on Q1 Earnings & Sales, Raises '26 EPS View
GSK Q1 Earnings Beat Estimates, Specialty Medicines Drive Sales Growth
Jim Cramer: This Tech Stock Is A 'Winner', Snap Does Not Have Growth
J&J Sees Continued MedTech Improvement in Q1, Eyes Better 2026
Johnson & Johnson $JNJ Shares Bought by Cadinha & Co. LLC
Arizona State Retirement System Lowers Stake in Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Sold by Absher Wealth Management LLC
Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch
Is Bristol Myers Squibb the Best Bargain in Big Pharma?
Boston Trust Walden Corp Has $138.37 Million Stake in Johnson & Johnson $JNJ
Caprock Group LLC Increases Stock Holdings in Johnson & Johnson $JNJ
B. Metzler seel. Sohn & Co. AG Purchases 45,458 Shares of Johnson & Johnson $JNJ
Gentry Private Wealth LLC Acquires Shares of 2,284 Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Purchased by Evergreen Capital Management LLC
J&J's Xarelto, Invokana to become available through TrumpRx
Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64%
J&J to buy private MedTech Atraverse to boost cardiac ablation portfolio
Belpointe Asset Management LLC Lowers Stock Holdings in Johnson & Johnson $JNJ
Benchmark Financial LLC Makes New Investment in Johnson & Johnson $JNJ
Focused Investors LLC Decreases Holdings in Johnson & Johnson $JNJ
Fortis Capital Advisors LLC Has $459,000 Stock Position in Johnson & Johnson $JNJ
55 North Private Wealth LLC Invests $692,000 in Johnson & Johnson $JNJ
JNJ set to snap six straight sessions of losses
SYRE Stock Jumps More Than 70% in a Month: What Is Driving This Rally?
BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize
BDTX Stock: Neutral Zacks Rank, $4 Target, and What Must Go Right
Black Diamond's Lead Drug Silevertinib: Key Data, Catalysts, and Risks
AbbVie Q1 Earnings Loom: Buy or Sell the Stock Ahead of Results?
Birch Hill Investment Advisors LLC Decreases Holdings in Johnson & Johnson $JNJ
Birch Hill Investment Advisors LLC Decreases Holdings in Johnson & Johnson $JNJ
First Horizon Corp Decreases Position in Johnson & Johnson $JNJ
First Horizon Corp Decreases Position in Johnson & Johnson $JNJ
Asset Management One Co. Ltd. Sells 4,633 Shares of Johnson & Johnson $JNJ
Small Cap or Megacap: Which Healthcare Stock Is Right for You?
Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges
J&J's Imaavy demonstrates long-term disease control in myasthenia gravis
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
J&J Innovative Medicine Drives Q1 Strength: Key to Long-Term Growth?
Abbott is the most oversold healthcare stock as Q1 earnings roll on
Forteris Wealth Management Inc. Buys Shares of 2,628 Johnson & Johnson $JNJ
AE Wealth Management LLC Grows Stake in Johnson & Johnson $JNJ
Semiconductors Look Dangerously Overheated After Massive Run: Analyst
3 Giant Dividend Stocks Raising Payouts With Yields Up to 4%